Mutational characterization of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Malaysia

Background and aim: Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21-OHD) is a common autosomal recessive disorder. Our objective was to identify the 21-hydroxylase active gene, CYP21A2 mutations in Malaysian 21-OHD patients using different techniques. Materials and methods: Blood samples were obtained from 97 Malaysian 21-OHD patients, which included 40 siblings from 19 families. We used various techniques which include restriction enzyme digestion, Southern blot, multiple ligation-dependent probe amplification (MLPA) and sequencing to elucidate CYP21A2 mutations. Results: Homozygous and compound heterozygous mutations were identified in 95 of the 97 patients (98%). Deletions of CYP21A2 were found in 43 patients (44.3%). Deletions identified in CYP21A2 gene were the usual 30-kb deletion comprising 3′UTR CYP21A1P, C4B and 5′CYP21A2, complete deletion of CYP21A2 gene. deletion in exons 1–3, exons 1–6 and exons 1–8 of CYP21A2. The common mutations identified in CYP21A2 gene were deletion/conversion (22.6%), p.R356W (22%), IVS2-13A/C>G (21.3%), p.I172N (5.3%), p.Q318X (5.3%), and p.P30L (1.03%). This is the first report of the mutation frequency in CYP21A2 gene among the Malay ethnic group. Two novel mutations, c.Y97insT and p.L345P were identified in our patients. Our results show good phenotype-genotype correlation in most of the cases, although clinical variations were identified in some patients. Conclusions: The study has found various mutations including deletions in CYP21A2 gene in Malaysian patients with 21-hydroxylase deficiency using the MLPA technique that is being widely used in present laboratory settings.

[1]  R. Khadgawat,et al.  Molecular genetic analysis of CYP21A2 gene in patients with congenital adrenal hyperplasia , 2012, Indian journal of endocrinology and metabolism.

[2]  C. Ki,et al.  Multiplex ligation-dependent probe amplification assay for diagnosis of congenital adrenal hyperplasia. , 2011, Annals of clinical and laboratory science.

[3]  H. Chaabouni,et al.  Detection of a Frequent Duplicated CYP21A2 Gene Carrying a Q318X Mutation in a General Population With Quantitative PCR Methods , 2011, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[4]  L. Fajkusová,et al.  Identification of CYP21A2 mutant alleles in Czech patients with 21-hydroxylase deficiency. , 2010, International journal of molecular medicine.

[5]  E. Capoluongo,et al.  Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: an update of new CYP21A2 mutations , 2010, Clinical chemistry and laboratory medicine.

[6]  G. Guerra‐Júnior,et al.  Novel deletion alleles carrying CYP21A1P/A2 chimeric genes in Brazilian patients with 21-hydroxylase deficiency , 2010, BMC Medical Genetics.

[7]  N. Krone,et al.  Genetics of congenital adrenal hyperplasia. , 2009, Best practice & research. Clinical endocrinology & metabolism.

[8]  V. Toscano,et al.  Multiplex ligation-dependent probe amplification (MLPA) assay for the detection of CYP21A2 gene deletions/duplications in congenital adrenal hyperplasia: first technical report. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[9]  H. Chao,et al.  Low frequency of the CYP21A2 deletion in ethnic Chinese (Taiwanese) patients with 21-hydroxylase deficiency. , 2008, Molecular genetics and metabolism.

[10]  H. Najmabadi,et al.  Ethnic-specific distribution of mutations in 716 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. , 2007, Molecular genetics and metabolism.

[11]  V. Prassolov,et al.  Four novel missense mutations in the CYP21A2 gene detected in Russian patients suffering from the classical form of congenital adrenal hyperplasia: identification, functional characterization, and structural analysis. , 2006, The Journal of clinical endocrinology and metabolism.

[12]  G. Federici,et al.  Divergent phenotype of two siblings human leukocyte antigen identical, affected by nonclassical and classical congenital adrenal hyperplasia caused by 21-hydroxylase deficiency. , 2006, The Journal of clinical endocrinology and metabolism.

[13]  T. Battelino,et al.  Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia. , 2005, European journal of endocrinology.

[14]  Yann-Jinn Lee,et al.  Use of PCR-based amplification analysis as a substitute for the southern blot method for CYP21 deletion detection in congenital adrenal hyperplasia. , 2004, Clinical chemistry.

[15]  Hsien-Hsiung Lee.  The chimeric CYP21P/CYP21 gene and 21-hydroxylase deficiency , 2004, Journal of Human Genetics.

[16]  L. B. Jemaa,et al.  Molecular genetic analysis of Tunisian patients with a classic form of 21-hydroxylase deficiency: identification of four novel mutations and high prevalence of Q318X mutation. , 2004, The Journal of clinical endocrinology and metabolism.

[17]  R. Průša,et al.  Frequency of CYP21 Gene Mutations in Czech Patients with Steroid 21-Hydroxylase Deficiency and Statistical Comparison with Other Populations , 2003, Medical Principles and Practice.

[18]  H. Degenhart,et al.  PCR-based detection of CYP21 deletions. , 2003, Clinical chemistry.

[19]  L. Hoefsloot,et al.  CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: six novel mutations and a specific cluster of four mutations. , 2003, The Journal of clinical endocrinology and metabolism.

[20]  S. Raskin,et al.  Deletion of the C4-CYP21 repeat module leading to the formation of a chimeric CYP21P/CYP21 gene in a 9.3-kb fragment as a cause of steroid 21-hydroxylase deficiency. , 2003, Clinical chemistry.

[21]  P. White,et al.  Congenital Adrenal Hyperplasia , 1964, The Lancet.

[22]  J. Yata,et al.  Genetic analysis of Japanese patients with 21-hydroxylase deficiency: identification of a patient with a new mutation of a homozygous deletion of adenine at codon 246 and patients without demonstrable mutations within the structural gene for CYP21. , 2002, The Journal of clinical endocrinology and metabolism.

[23]  Y. Lee,et al.  Molecular Analysis of CYP-21 Mutations for Congenital Adrenal Hyperplasia in Singapore , 2001, Hormone Research in Paediatrics.

[24]  A. Grüters,et al.  How a patient homozygous for a 30-kb deletion of the C4-CYP 21 genomic region can have a nonclassic form of 21-hydroxylase deficiency. , 2000, The Journal of clinical endocrinology and metabolism.

[25]  A. Braun,et al.  Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. , 2000, The Journal of clinical endocrinology and metabolism.

[26]  A. Iolascon,et al.  21-hydroxylase deficiency in Italy: a distinct distribution pattern ofCYP21 mutations in a sample from southern Italy , 1999, Journal of medical genetics.

[27]  T. R. Welch,et al.  Modular Variations of the Human Major Histocompatibility Complex Class III Genes for Serine/Threonine Kinase RP, Complement Component C4, Steroid 21-Hydroxylase CYP21, and Tenascin TNX (the RCCX Module) , 1999, The Journal of Biological Chemistry.

[28]  A. Wedell.  Molecular approaches for the diagnosis of 21-hydroxylase deficiency and congenital adrenal hyperplasia. , 1996, Clinics in laboratory medicine.

[29]  M. Tusié-Luna,et al.  Gene conversions and unequal crossovers between CYP21 (steroid 21-hydroxylase gene) and CYP21P involve different mechanisms. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[30]  H. Luthman,et al.  Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation. , 1994 .

[31]  M. Tassabehji,et al.  Identification of a novel family of human endogenous retroviruses and characterization of one family member, HERV-K(C4), located in the complement C4 gene cluster. , 1994, Nucleic acids research.

[32]  M. Tusié-Luna,et al.  Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 1992, The Journal of clinical investigation.

[33]  P. White,et al.  Genetic basis of endocrine disease 2: congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 1992, The Journal of clinical endocrinology and metabolism.

[34]  T. Sasazuki,et al.  Gene conversion in steroid 21-hydroxylase genes. , 1990, American journal of human genetics.

[35]  K. Fujieda,et al.  Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 1988, Pediatrics.

[36]  P. White,et al.  Characterization of frequent deletions causing steroid 21-hydroxylase deficiency. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Y. Fujii‐Kuriyama,et al.  Evidence for frequent gene conversion in the steroid 21-hydroxylase P-450(C21) gene: implications for steroid 21-hydroxylase deficiency. , 1988, American journal of human genetics.

[38]  P. White,et al.  Congenital adrenal hyperplasia. (First of two parts) , 1987 .

[39]  P. White,et al.  Structure of human steroid 21-hydroxylase genes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[40]  P. Donohoue,et al.  Gene conversion in salt-losing congenital adrenal hyperplasia with absent complement C4B protein. , 1986, The Journal of clinical endocrinology and metabolism.

[41]  O. Gotoh,et al.  Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[42]  P. White,et al.  HLA-linked congenital adrenal hyperplasia results from a defective gene encoding a cytochrome P-450 specific for steroid 21-hydroxylation. , 1984 .

[43]  M. New,et al.  Congenital adrenal hyperplasia. , 1988, Biochemical Society transactions.